OUR PRODUCTS

MOBILE APPS

GENERAL INFO

GNLX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Genelux (GNLX) Earnings Date & Reports

Genelux Corp is a clinical-stage biopharmaceutical company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GNLX is expected to report earnings to rise 10.00% to -21 cents per share on November 12

Q3'25

Est.

$-0.22

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.01

Q4'24

Est.

$-0.25

Q3'24

Beat

by $0.06

The last earnings report on August 07 showed earnings per share of -20 cents, beating the estimate of -21 cents. With 110.62K shares outstanding, the current market capitalization sits at 134.47M.

View a ticker or compare two or three

Compare

GNLX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GNLX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GNLX showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2625 Townsgate Road

Phone

+1 805 267-9889

Employees

Web

https://www.genelux.com